Donald Pearl
Directeur/Membre du Conseil chez Child Neurology Foundation
Profil
Donald Pearl is currently the Director at Child Neurology Foundation.
Prior to this, he was the Chief Executive Officer at Aruene Corp.
in 2020 and the Vice President-Neurology at Ipsen Biopharmaceuticals, Inc. from 2014 to 2019.
Postes actifs de Donald Pearl
| Sociétés | Poste | Début |
|---|---|---|
| Child Neurology Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Donald Pearl
| Sociétés | Poste | Fin |
|---|---|---|
Aruene Corp.
 Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Directeur Général | 01/08/2020 |
| Ipsen Biopharmaceuticals, Inc. | Corporate Officer/Principal | 01/04/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Health Technology |
| Child Neurology Foundation | |
| Ipsen Biopharmaceuticals, Inc. |